Related Experiment Video

Updated: Aug 19, 2026

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

The integration of pharmacokinetics and pathogen susceptibility data in the design of rational dosing regimens

D Maglio1, D P Nicolau

  • 1Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, Connecticut 06102-5037, USA.

Methods and Findings in Experimental and Clinical Pharmacology
|January 27, 2005
PubMed

Insights

Pharmacokinetic/pharmacodynamic (PK/PD) parameters, like AUC/MIC, improve antimicrobial dosing. PK/PD breakpoints predict treatment success, guiding targeted infectious disease therapy and novel drug development.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Drug Development

Background:

  • Minimum inhibitory concentration (MIC) indicates drug potency but doesn't predict in vivo response with fluctuating drug levels.
  • Pharmacokinetic/pharmacodynamic (PK/PD) parameters integrate drug concentration and effect data for better prediction.
  • PK/PD parameters such as AUC/MIC, Cmax/MIC, and %T>MIC are crucial for optimizing antimicrobial dosage regimens.

Purpose of the Study:

  • To highlight the utility of PK/PD parameters in designing effective antimicrobial dosage regimens.
  • To demonstrate the predictive value of PK/PD breakpoints for clinical outcomes in infectious diseases.
  • To underscore the role of PK/PD assessments in targeted antimicrobial therapy selection and novel dosing strategies.

Main Methods:

  • Experimental models of infection were used to determine optimal PK/PD parameter magnitudes (AUC/MIC, Cmax/MIC, %T>MIC) for specific pathogens.
  • PK/PD breakpoints were established based on achieving target PK/PD parameter values with specific dosing regimens.
  • Correlation between PK/PD breakpoints and clinical outcomes was assessed, particularly in infections like otitis media.

Main Results:

  • Specific PK/PD parameter values (AUC/MIC, Cmax/MIC, %T>MIC) were identified as critical for effective treatment of various pathogens.
  • PK/PD breakpoints demonstrated a strong correlation with treatment success or failure.
  • The predictive power of PK/PD breakpoints was particularly evident in infections allowing for microbiologic sampling.

Conclusions:

  • PK/PD assessments provide a targeted approach to infectious disease treatment.
  • PK/PD parameters and breakpoints are valuable tools for selecting antimicrobial therapy and developing new dosing strategies.
  • The integration of PK/PD data enhances the design of antimicrobial dosage regimens, improving patient outcomes.

More Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Related Concept Videos

Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.